ANI
26 May 2023, 16:25 GMT+10
New Delhi [India], May 26 (ANI) Elon Musk's firm Neuralink on Friday said it received US Food and Drug Administration (FDA)'s approval for conducting its first test on humans.
In a tweet, Neuralink expressed its excitement, "We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study! This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people."The firm added, "Recruitment is not yet open for our clinical trial. We'll announce more information on this soon!." This approval is seen as a crucial step forward for Neuralink's groundbreaking technology.
Neuralink, acquired by Musk, describes the technique where a sewing machine-like robot implants ultrathin threads deep into the brain, according to The New York Times reports.
Neuralink said that currently, the insertion of wiring requires surgeons to drill holes through the skull. In the future, they hope to use a laser beam to pierce the skull for minimal sensation and pain.
Electric car firm Telsa's Chief Executive Officer Elon Musk had previously explained that the implantable Neuralink device would enable individuals to interact with computers using their minds.
Musk during a presentation had earlier claimed that the implant could make computer control possible for people with paralysis outside of a lab setting. Neuralink's engineering work is an important advance, he added, but the results shown by the company were not as important.
The presentation focused on the "Link" device, which resembles an inch-wide stack of several coins with hundreds of hair-thin threads, according to the New York Times.
A surgical robot would cut a hole in the skull and slip the electrode threads into the gray matter of the brain, according to Musk's 2020 company presentation. The coin-like piece would sit flush with the skull, NYT said.
According to NYT, while the potential use cases are plenty, Musk's idea behind the ambitious system is medical use, such as helping amputees regain mobility or helping people hear, speak, or see. (ANI)Get a daily dose of Dublin News news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Dublin News.
More InformationFRANKLIN, Tennessee: Hundreds of thousands of Nissan and Infiniti vehicles are being recalled across the United States due to a potential...
REDMOND, Washington: Microsoft is the latest tech giant to announce significant job cuts, as the financial strain of building next-generation...
LONDON UK - U.S. stock markets were closed on Friday for Independence Day. Global Forex Markets Wrap Up Friday with Greeback Comeback...
SANTA CLARA, California: Nvidia came within a whisker of making financial history on July 3, briefly surpassing Apple's all-time market...
SACRAMENTO, California: California's multibillion-dollar farms are facing a growing crisis—not from drought or pests, but from a sudden...
WASHINGTON, D.C.: President Donald Trump says the United States could soon reach a trade deal with India. He believes this deal would...
LONDON, U.K.: An unrelenting heatwave sweeping across Europe has pushed early summer temperatures to historic highs, triggering deadly...
DUBLIN, Ireland: Tánaiste Simon Harris has called on the United States to use every hour to reach a zero-for-zero tariff agreement...
DUBLIN, Ireland: A blind woman from Dublin says she was hurt while getting off a bus because the driver refused to pull in close to...
DUBLIN, Ireland: The Irish Nurses and Midwives Organisation (INMO) has warned that there could be a serious trolley crisis this summer...
ISTANBUL/PARIS/BRUSSELS: As searing temperatures blanket much of Europe, wildfires are erupting and evacuation orders are being issued...
NEW YORK CITY, New York: The U.S. dollar continues to lose ground, weighed down by growing concerns over Washington's fiscal outlook...